Khôi phục và kiểm tra hạch bạch huyết trong quá trình thực hiện cắt bỏ hạch bạch huyết mở rộng cho ung thư dạ dày tại một cơ sở không chuyên tại phương Tây

Maruyama K (1986) Surgical treatment and end result of gastric cancer. National Cancer Center Press, Tokyo Sano T, Sasako M, Yamamoto S et al (2004) Gastric cancer surgery: morbidity and mortality results from a prospective randomized controlled trial comparing D2 and extended para-aortic lymphadenectomy—Japan Clinical Oncology Group Study 9501. J Clin Oncol 22:2767–2773 Siewert JR, Bottcher K, Roder D, Busch R, Hermanek P, Meyer HJ (1993) Prognostic relevance of systematic lymph node dissection in gastric carcinoma. Br J Surg 80:1015–1018 Siewert JR, Kestlmeier R, Busch R et al (1996) Benefits of D2 lymph node dissection for patients with gastric cancer and pN0 and pN1 lymph node metastases. Br J Surg 83:1144–1147 Jaehne J, Meyer H-J, Mascher H, Geerlings H, Pichlmayr R (1992) Lymphadenectomy in gastric carcinoma. Arch Surg 127:290–294 Biffi R, Chiappa A, Luca F, Pozzi S, Lo Faso F, Cenciarelli S, Andreoni B (2006) Extended lymph-node dissection without routine spleno-pancreatectomy for treatment of gastric cancer: low morbidity and mortality rates in a single center series of 250 patients. J Surg Oncol 93:394–400 De Giuli M, Sasako M, Calgaro M et al (2004) Morbidity and mortality after D1 and D2 gastrectomy for cancer: interim analysis of the Italian Gastric Cancer Study Group (IGCSG) randomised surgical trial. Eur J Surg Oncol 30:303–308 Marrelli D, Pedrazzani C, Neri A, Corso G, DeStefano A, Pinto E, Roviello F (2007) Complications after extended (D2) and superextended (D3) lymphadenectomy for gastric cancer: analysis of potential risk factors. Ann Surg Oncol 14:25–33 Cuschieri A, Weeden S, Fielding J, Bancewicz J, Craven J, Joypaul V, Sydes M, Fayers P (1999) Patient survival after D1 And D2 resections for gastric cancer: long-term result of the MRC randomised controlled surgical trial. Br J Surg 79:1522–1530 Bonenkamp JJ, Hermans J, Sasako M, Van De Velde CJH, for the Dutch Gastric Cancer Group (1999) Extended lymph node dissection for gastric cancer. N Engl J Med 340:908–914 McCulloch P, Niita EM, Kazi H, Gama-Rodriguez J (2005) Gastrectomy with extended lymphadenectomy for primary treatment of gastric cancer. Br J Surg 92:5–13 Sobin LH, Wittekind CH, International Union Against Cancer (UICC) (1997) TNM classification of malignant tumors, 5th edn. Wiley-Liss, New York Wagner PK, Ramaswamy A, Ruschoff J, Schmitz-Moormann P, Rothmund M (1991) Lymph node counts in the upper abdomen: anatomical basis for lymphadenectomy in gastric cancer. Br J Surg 78:825–827 Sharma D, Thakur A, Toppo S, Chandrakar SK (2005) Lymph node counts in Indians in relation to lymphadenectomy for carcinoma of the oesophagus and stomach. Asian J Surg 28:116–120 Bouvier AM, Haas O, Piard F, Roignot P, Bonithon-Kopp C, Faivre J (2002) How many nodes must be examined to accurately stage gastric carcinomas? Results from a population based study. Cancer 94:2862–2866 Baxter NN, Tuttle TM (2005) Inadequacy of lymph node staging in gastric cancer patients: a population-based study. Ann Surg Oncol 12:981–987 Coburn NG, Swallow CJ, Kiss A, Law C (2006) Significant regional variation in adequacy of lymph node assessment and survival in gastric cancer. Cancer 107:2143–2151 Japanese Gastric Cancer Association (1998) Japanese classification of gastric carcinoma—2nd English edition. Gastric Cancer 1:10–24 Siewert JR, Feith M, Stein HJ (2005) Biologic and clinical variations of adenocarcinoma at the esophago-gastric junction: relevance of a topographic-anatomic subclassification. J Surg Oncol 90:139–146 Lauren P (1965) The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification. Acta Pathol Microbiol Scand 64:31–49 Maruyama K, Sasako M, Kinoshita T, Sano T, Katai H, Okajima K (1995) Pancreas-preserving total gastrectomy for proximal gastric cancer. World J Surg 19:532–536 Draper NR, Smith H (1998) Applied regression analysis, 3rd edn. Wiley, New York Davis PA, Sano T (2001) The difference in gastric cancer between Japan, USA and Europe: what are the facts? What are the suggestions? Crit Rev Oncol Hematol 40:77–94 Catarci M, Guadagni S, Zaraca F et al (1998) Prospective randomized evaluation of preoperative endoscopic vital staining using CH-40 for lymph node dissection in gastric cancer. Ann Surg Oncol 5:580–584 Candela FC, Urmacher C, Brennan MF (1990) Comparison of the conventional method of lymph node staging with a comprehensive fat-clearing method for gastric adenocarcinoma. Cancer 66:1828–1832 Koren R, Kyzer S, Levin I, Klein B, Halpern M, Rath-Wolfson L, Paz A, Melloul MM, Mishali M, Gal R (1997) Lymph node revealing solution: a new method for lymph node sampling. Results in gastric adenocarcinoma. Oncol Rep 5:341–344 Schoenleber SJ, Schnelldorfer T, Wood CM, Qin R, Sarr MG, Donohue JH (2009) Factors influencing lymph node recovery from the operative specimen after gastrectomy for gastric adenocarcinoma. J Gastrointest Surg 13:1233–1237 Hammond EH, Henson DE (1995) The role of pathologists in cancer patient staging. Cancer Committee. Am J Clin Pathol 103:679–680 Noda N, Sasako M, Yamaguchi N, Nakanishi Y (1998) Ignoring small lymph nodes can be a major cause of staging error in gastric cancer. Br J Surg 85:831–834 Marchet A, Morcellin S, Ambrosi et al (2007) The ratio between metastatic and examined lymph nodes (N ratio) is and independent prognostic factor in gastric cancer regardless the type of lymphadenectomy. Ann Surg 245:543–552 Cheong JH, Hyung WJ, Shen JG et al (2006) The N ratio predicts recurrence and poor prognosis in patients with node-positive early gastric cancer. Ann Surg Oncol 13:377–385 Xu D, Geng Q, Long Z et al (2009) Positive lymph node ratio is an independent prognostic factor in gastric cancer after D2 resection regardless of the examined number of lymph nodes. Ann Surg Oncol 16:319–326